Summary:
Study Summary: This study is designed to evaluate biomarkers
associated with diagnostic assay development. This is a prospective study
requiring full patient consent for enrollment. Biologic material and clinical data
must be provided and de-identified. Only the physician/CRC/pathology staff may
have access to confidential patient data.
Qualified Participants Must:
• Participant must be at least 18 years old
•
Non-Alcoholic Fatty Liver Disease/ NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease
•
Liver Cirrhosis
•
Celiac Disease
•
Cancer
•
Liver, Heart, Kidney Transplant
•
Patients who will be starting Humira/biosimilars